TY - JOUR
T1 - Insulin-like growth factor-1 induces lipid production in human SEB-1 sebocytes via sterol response element-binding protein-1
AU - Smith, Terry M.
AU - Cong, Zhaoyuan
AU - Gilliland, Kathryn L.
AU - Clawson, Gary A.
AU - Thiboutot, Diane M.
N1 - Funding Information:
We thank Anthony W. Gebhard for technical assistance. This work is supported by NIH NIAMS R01AR AR047820 to D.M.T. and the Jake Gittlen Cancer Institute at the Pennsylvania State University College of Medicine.
PY - 2006/6
Y1 - 2006/6
N2 - An understanding of the molecular signaling involved in sebaceous gland lipid production is needed to develop therapeutic targets to improve acne. Treatment with methylisobutylxanthine, dexamethasone, and a high dose of insulin (MDI) has been shown to differentiate 3T3-L1 preadipocytes into adipocytes, a differentiation marked by an increase in lipid production. The present study has the following aims: (1) Since high doses of insulin, as found in MDI, will activate the IGF-1 receptor, we sought to determine if IGF-1 is capable of reproducing the lipogenic effect seen with MDI treatment, and (2) to determine if the sterol response element-binding protein-1 (SREBP-1) pathway mediates the increase in lipogenesis. Here we report that MDI increases lipogenesis and that this effect can be attributed wholly to the high-dose insulin in SEB-1 cells. Further, we show that a physiologically relevant dose of IGF-1 or high-dose (1 μM) insulin induces an increase in SREBP-1 mRNA, protein, and total lipid production; while 100 nM insulin induces lipogenesis yet the SREBP protein levels remain unchanged. These data indicate that activation of the IGF-1 receptor increases lipogenesis in SEB-1 cells through both SREBP-dependent and SREBP-independent pathways.
AB - An understanding of the molecular signaling involved in sebaceous gland lipid production is needed to develop therapeutic targets to improve acne. Treatment with methylisobutylxanthine, dexamethasone, and a high dose of insulin (MDI) has been shown to differentiate 3T3-L1 preadipocytes into adipocytes, a differentiation marked by an increase in lipid production. The present study has the following aims: (1) Since high doses of insulin, as found in MDI, will activate the IGF-1 receptor, we sought to determine if IGF-1 is capable of reproducing the lipogenic effect seen with MDI treatment, and (2) to determine if the sterol response element-binding protein-1 (SREBP-1) pathway mediates the increase in lipogenesis. Here we report that MDI increases lipogenesis and that this effect can be attributed wholly to the high-dose insulin in SEB-1 cells. Further, we show that a physiologically relevant dose of IGF-1 or high-dose (1 μM) insulin induces an increase in SREBP-1 mRNA, protein, and total lipid production; while 100 nM insulin induces lipogenesis yet the SREBP protein levels remain unchanged. These data indicate that activation of the IGF-1 receptor increases lipogenesis in SEB-1 cells through both SREBP-dependent and SREBP-independent pathways.
UR - http://www.scopus.com/inward/record.url?scp=33745530927&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33745530927&partnerID=8YFLogxK
U2 - 10.1038/sj.jid.5700278
DO - 10.1038/sj.jid.5700278
M3 - Article
C2 - 16575389
AN - SCOPUS:33745530927
SN - 0022-202X
VL - 126
SP - 1226
EP - 1232
JO - Journal of Investigative Dermatology
JF - Journal of Investigative Dermatology
IS - 6
ER -